Zn-Thymulin

What is Zn-thymulin?

Thymulin is a small hormone made by the thymus, the gland behind the breastbone where T cells mature. It is a nonapeptide, a chain of nine amino acids. It was identified in the 1970s by Jean-François Bach's group in Paris, who first called it facteur thymique sérique, or serum thymic factor. Researchers later found that it only works when bound to a zinc atom, so the active form is often written as zinc-thymulin or Zn-thymulin.

Thymulin is one of several signals the thymus uses to support immune development. One review describes packaging zinc into zinc-thymulin for delivery to the rest of the body as an important endocrine function of the thymus.¹

Today, synthetic thymulin is sold online in two forms: as an injectable research peptide marketed for immune support, and in topical serums for thinning hair. It is not approved as a drug for any use, and the human evidence for either purpose is very limited.

How Zn-thymulin works

Think of thymulin as a messenger that tells immature immune cells how to develop into working T cells. It needs zinc to do that job. Without enough zinc, the thymus can still make the peptide, but it circulates in an inactive form. That is why zinc deficiency weakens immune function, and why blood thymulin activity has been used as a sensitive marker of zinc status.

Thymulin levels fall as the thymus shrinks with age, which is one reason it attracts interest in research on immune aging. It also has anti-inflammatory and pain-reducing effects in animal models, which suggests a role beyond T-cell development.

In more precise terms, thymulin has the sequence pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn and binds zinc in a one-to-one complex that changes its shape and makes it biologically active. Thymic function depends on a network of local signals, including several interleukins, interferon-gamma, thymosin alpha-1 and zinc-thymulin.¹ The receptors through which thymulin acts on T cells and other tissues are not fully characterized. Its proposed effect on hair follicles is even less well defined.

What the research shows on Zn-thymulin

The clearest human evidence concerns thymulin as a marker, not as a treatment. In a study of 51 children with Down syndrome, plasma zinc and thymulin levels were low compared with controls. Dietary zinc supplementation restored both zinc and thymulin, along with some thyroid measures. When zinc was stopped, zinc levels fell again a year later.³ This shows that thymulin activity in the body depends on zinc intake, and that zinc itself can raise it.

Animal work suggests thymulin can influence immune aging. In aged mice stressed with hydrocortisone, researchers reported that oral zinc, zinc-thymulin and thymosin alpha-1 each helped reverse thymic shrinkage and improved T-cell responses.² The same research program has tried several ways to treat thymic involution, including thymic hormones and zinc.¹ These are animal results, and they do not show that injecting synthetic thymulin helps healthy adults.

Other animal studies report that thymulin reduces inflammation and pain signaling, but these findings have not been tested in human trials. Most of this work used small numbers of animals, short treatment periods and injected doses that do not map neatly onto human products.

For hair loss, commercial interest comes mostly from cosmetic marketing. The human evidence consists of small studies, and no large randomized controlled trial of topical thymulin for any type of hair loss has been published. Its effects cannot be compared with approved hair-loss treatments.

Studied for: Immune modulation research, Hair loss research.

Zn-Thymulin reference data

Zn-Thymulin dosage in published research

How Zn-thymulin is used in practice

Thymulin reaches consumers through two channels. Cosmetic hair serums containing thymulin or "thymus peptides" are sold online and in salons, usually as one ingredient among several, which makes it impossible to tell what any single ingredient contributes. These products are sold as cosmetics, not drugs, so their claims are not reviewed by the FDA for efficacy. Labels rarely state how much thymulin a product contains, and independent testing of these serums is scarce.

The second channel is research-peptide vendors, who sell lyophilized thymulin for injection. Some wellness clinics have used it as part of immune or anti-aging protocols. This supply is unregulated, with no assurance of purity, sterility or correct dosing. Whether a synthetic product contains the right amount of zinc for activity is another open question.

Because thymulin depends on zinc, some practitioners pair it with zinc supplements. Given the human data, simply correcting a zinc deficiency is the better-supported step.³

Zn-thymulin risks and side effects

Topical products may cause scalp irritation, itching or contact dermatitis, often from other ingredients in the formula. Injections can cause redness, swelling or pain at the site.

Because thymulin is meant to influence immune development, people with autoimmune disease or who take immunosuppressive drugs should be cautious. It has not been studied in pregnancy or in children outside of zinc research. Long-term effects of repeated injections are unknown. There are no formal drug interaction studies.

Zinc status changes how thymulin behaves, so results may vary with diet and supplements. Too much supplemental zinc has its own risks, including copper deficiency. Gray-market injectable products add the risks of contamination, mislabeling and nonsterile solutions.

Reported side effects

Alternatives to Zn-thymulin

For hair loss, approved and well-studied options include topical minoxidil for men and women, and oral finasteride for men with pattern hair loss. Low-dose oral minoxidil and spironolactone are common off-label options. For alopecia areata, JAK inhibitors such as baricitinib and ritlecitinib are FDA approved. GHK-Cu is another peptide marketed for hair, also with limited human evidence.

For immune support, correcting zinc deficiency, staying current with vaccines, regular exercise and sleep have much better evidence. Among thymic peptides, thymosin alpha-1 has a larger body of human trials.

Questions for a clinician

• What evidence applies to my situation, and at what level?
• What established alternatives should I consider first?
• What monitoring would be necessary, and how often?
• Can this be prescribed at all where I live, or only sold for research?